a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders.
Industry Biotechnology
A.I.dvisor indicates that over the last year, NRBO has been loosely correlated with TCRT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NRBO jumps, then TCRT could also see price increases.
Ticker / NAME | Correlation To NRBO | 1D Price Change % | ||
---|---|---|---|---|
NRBO | 100% | -7.11% | ||
TCRT - NRBO | 50% Loosely correlated | -10.59% | ||
ARGX - NRBO | 45% Loosely correlated | -5.18% | ||
BLUE - NRBO | 37% Loosely correlated | -11.53% | ||
SYRE - NRBO | 37% Loosely correlated | -6.62% | ||
AKRO - NRBO | 32% Poorly correlated | -5.61% | ||
More |